9-[N-gamma-(3'-(nitrooxy)propyl)-gamma-aminobutylamino]-1,2,3,4-tetrahydroacridine

ID: ALA407320

Chembl Id: CHEMBL407320

PubChem CID: 24800128

Max Phase: Preclinical

Molecular Formula: C20H28N4O3

Molecular Weight: 372.47

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=[N+]([O-])OCCCNCCCCNc1c2c(nc3ccccc13)CCCC2

Standard InChI:  InChI=1S/C20H28N4O3/c25-24(26)27-15-7-13-21-12-5-6-14-22-20-16-8-1-3-10-18(16)23-19-11-4-2-9-17(19)20/h1,3,8,10,21H,2,4-7,9,11-15H2,(H,22,23)

Standard InChI Key:  NJRCJWGDCROWEJ-UHFFFAOYSA-N

Associated Targets(Human)

ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Tclin Butyrylcholinesterase (7174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Artery (19 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ache Acetylcholinesterase (12221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Butyrylcholinesterase (805 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 372.47Molecular Weight (Monoisotopic): 372.2161AlogP: 3.49#Rotatable Bonds: 11
Polar Surface Area: 89.32Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.53CX LogP: 3.21CX LogD: -1.00
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.36Np Likeness Score: -0.85

References

1. Fang L, Appenroth D, Decker M, Kiehntopf M, Roegler C, Deufel T, Fleck C, Peng S, Zhang Y, Lehmann J..  (2008)  Synthesis and biological evaluation of NO-donor-tacrine hybrids as hepatoprotective anti-Alzheimer drug candidates.,  51  (4): [PMID:18232655] [10.1021/jm701491k]
2. Fang L, Appenroth D, Decker M, Kiehntopf M, Lupp A, Peng S, Fleck C, Zhang Y, Lehmann J..  (2008)  NO-donating tacrine hybrid compounds improve scopolamine-induced cognition impairment and show less hepatotoxicity.,  51  (24): [PMID:19053746] [10.1021/jm801131a]

Source